Clinical Trial Update: Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)

View source ↗

Summary

The K-XIENCE Registry evaluating everolimus-eluting stents for coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• XIENCE everolimus-eluting stent (everolimus)

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Status: COMPLETED